Showing results (1771-1780 of 2,456) with videos related to
Sort By:
Pageof 246
Clinical Pharmacology and Therapeutics|February 12, 2015
Catalyzing the Critical Path Initiative: FDA's progress in drug development activitiesA Parekh, S Buckman-Garner, S McCune, et al.The Prostate|February 22, 2023
Low-risk prostate lesions: An evidence review to inform discussion on losing the "cancer" labelCaitlin R Semsarian, Tara Ma, Brooke Nickel, et al.Disease Models & Mechanisms|March 9, 2013
A murine Zic3 transcript with a premature termination codon evades nonsense-mediated decay during axis formationJehangir N Ahmed, Radiya G Ali, Nicholas Warr, et al.The Journal of Pediatrics|November 5, 1999
Urinary supersaturation of calcium oxalate and phosphate in patients with X-linked hypophosphatemic rickets and in healthy schoolchildrenL Patzer, W van't Hoff, V Shah, et al.Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|September 14, 2002
Comparison of the effects of antihypertensive treatment with angiotensin II blockade and beta-blockade on carotid wall structure and haemodynamics: protocol and baseline demographicsBen Ariff, Alice Stanton, Dean Barratt, et al.The International Journal on Drug Policy|December 24, 2021
Impacts of changes in alcohol consumption patterns during the first 2020 COVID-19 restrictions for people with and without mental health and neurodevelopmental conditions: A cross sectional study in 13 countriesEmma L Davies, Cheneal Puljevic, Gail Gilchrist, et al.Research Report (Health Effects Institute)|February 10, 2012
The London low emission zone baseline studyFrank Kelly, Ben Armstrong, Richard Atkinson, et al.Journal of Health Care for the Poor and Underserved|February 14, 2022
Comparing Echocardiograms of Haitian and non-Haitian Stroke PatientsRoshan Bransden, Dianelis Hernandez, Stephanie Mangels, et al.Harm Reduction Journal|January 9, 2023
'We don't live in a harm reduction world, we live in a prohibition world': tensions arising in the design of drug alertsIsabelle Volpe, Rita Brien, Jasmin Grigg, et al.The EMBO Journal|July 15, 1996
Structure of a specific peptide complex of the carboxy-terminal SH2 domain from the p85 alpha subunit of phosphatidylinositol 3-kinaseA L Breeze, B V Kara, D G Barratt, et al.Pageof 246